Senti Biosciences Inc (SNTI)
Healthcare
Biotechnology
0.34 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Senti Biosciences Inc (SNTI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 40.0% of the shares are freely tradable; institutional investors hold 18.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
18.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
47.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
40.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
31Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| NEA Management Company, LLC | 12.12 | 3,775,615 | +0.0 | 03/31/2026 |
| Nantahala Capital Management, LLC | 2.85 | 888,000 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.02 | 628,697 | +2.0 | 12/31/2025 |
| Geode Capital Management, LLC | 0.66 | 207,043 | +43.0 | 03/31/2026 |
| MSOP GP, LLC | 0.11 | 35,737 | +0.0 | 12/31/2025 |
| Menlo Ventures Management, L.P. | 0.11 | 35,737 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.18 | 368,878 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.54 | 168,626 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.37 | 115,844 | -0.4 | 04/30/2026 |
| Abante Quant Value FI | 0.32 | 99,319 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.